Godrej Agrovet Board Approves Q3FY26 Investor Presentation: Revenue Surges 11%

3 min read     Updated on 03 Feb 2026, 05:03 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Godrej Agrovet's Board of Directors approved the Q3FY26 investor presentation on February 3, 2026, showcasing exceptional quarterly performance with 11% revenue growth to ₹2,718 crore and EBITDA margin expansion to 9.6%. The company demonstrated strong operational execution across key segments including 21% cattle feed volume growth in Animal Feed business and 27% revenue growth in Vegetable Oil segment.

31664037

*this image is generated using AI for illustrative purposes only.

The Board of Directors of Godrej Agrovet Limited approved the investor presentation for Q3FY26 results at their meeting held on February 3, 2026. The company announced its unaudited financial results for Q3FY26 ended December 31, 2025, delivering exceptional performance with revenue growth of 11% and strong profitability improvements. The company reported consolidated net profit of ₹110 crore and revenue from operations of ₹2,718 crore, demonstrating robust operational execution across key business segments.

Board Meeting and Regulatory Compliance

The Board meeting held on February 3, 2026, approved both standalone and consolidated unaudited financial results for the quarter and nine months period ended December 31, 2025. The investor presentation has been placed on the company's website at www.godrejagrovet.com and communicated to BSE Limited and National Stock Exchange of India Limited pursuant to Regulations 30, 33 and 52(4) of SEBI Listing Regulations.

Meeting Details: Information
Meeting Date: February 3, 2026
Results Period: Q3FY26 ended December 31, 2025
BSE Scrip Code: 540743
NSE Symbol: GODREJAGRO
Website: www.godrejagrovet.com

Financial Performance Overview

The company's Q3FY26 consolidated performance showcases strong double-digit revenue growth with enhanced profitability metrics. EBITDA improved to ₹260 crore from ₹229 crore in the corresponding quarter last year, with EBITDA margin expanding to 9.6% from 9.3% year-on-year. Profit before tax registered impressive growth of 23.1% to ₹169 crore, reflecting sustained margin expansion and operational efficiencies.

Financial Metric: Q3FY26 Q3FY25 Y-o-Y Change
Revenue from Operations: ₹2,718 crore ₹2,450 crore +11.0%
EBITDA: ₹260 crore ₹229 crore +13.6%
EBITDA Margin: 9.6% 9.3% +30 bps
Profit Before Tax: ₹169 crore ₹138 crore +23.1%
Net Profit: ₹110 crore ₹110 crore 0%
PAT Margin: 4.0% 4.5% -50 bps

Segment-wise Business Performance

The company's diversified business model demonstrated strong performance across multiple segments. Animal Feed business achieved robust volume growth driven by 21% year-on-year growth in cattle feed, while Vegetable Oil segment registered healthy 27% revenue growth supported by 16% improvement in Fresh Fruit Bunch arrivals and enhanced Oil Extraction Ratio.

Business Segment: Q3FY26 Performance Key Highlights
Animal Feed: 2% revenue growth 21% cattle feed volume growth
Vegetable Oil: 27% revenue growth 16% FFB growth, improved OER
Crop Protection: Flat margins Weather-related headwinds
Astec LifeSciences: Positive EBITDA Strong volume recovery
Dairy: 3% revenue growth Higher procurement costs impact
Poultry & Processed Food: 51% EBITDA growth 81% branded salience

Nine Months Performance

For the nine months ended December 31, 2025, the company achieved consolidated revenue from operations of ₹7,900 crore compared to ₹7,249 crore in the corresponding period last year, representing 9.0% growth. Net profit for the nine-month period stood at ₹343 crore versus ₹337 crore in the previous year, with EBITDA margin maintained at 9.7%.

Management Commentary and Outlook

Commenting on the performance, Managing Director Sunil Kataria highlighted Q3FY26 as an exceptional quarter with robust double-digit revenue growth and strong profitability improvement. The performance was driven by sustained margin expansion across key businesses, supported by sharp operational execution and continued focus on value creation. All key businesses, particularly Vegetable Oil, Animal Feed and Poultry, delivered solid improvements with enhanced operational parameters and strategic initiatives yielding positive results.

Historical Stock Returns for Godrej Agrovet

1 Day5 Days1 Month6 Months1 Year5 Years
-1.00%+0.02%+24.43%-14.44%-14.65%+32.07%

Godrej Agrovet Limited Schedules Conference Call for Q3FY26 Results Discussion on February 4, 2026

1 min read     Updated on 16 Jan 2026, 02:50 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Godrej Agrovet Limited has scheduled a conference call for February 4, 2026, at 3:30 PM IST to discuss Q3FY26 and 9MFY26 financial results. The call, hosted by Equirus Securities, will feature senior management including Chairman Nadir Godrej and CEO Sunil Kataria. Multiple international dial-in options are available for participants, with the session format including management discussion followed by Q&A.

30100852

*this image is generated using AI for illustrative purposes only.

Godrej Agrovet Limited has formally notified stock exchanges about an upcoming conference call with investors and analysts to discuss its Q3FY26 and 9MFY26 financial results. The company filed the intimation with BSE Limited and National Stock Exchange of India Limited on January 16, 2026.

Conference Call Details

The earnings call is scheduled for Wednesday, February 4, 2026, at 3:30 PM IST. Equirus Securities will host the conference call on behalf of Godrej Agrovet Limited following the announcement of financial results for the quarter and nine months ended December 31, 2025.

Parameter: Details
Date: Wednesday, February 4, 2026
Time: 3:30 PM IST
Host: Equirus Securities
Call Leader: Siddharth Gadekar, Equirus Securities

Management Participation

The conference call will feature senior management representatives who will participate in the earnings discussion and Q&A session:

  • Mr. Nadir Godrej – Chairman
  • Mr. Sunil Kataria – Chief Executive Officer & Managing Director
  • Mr. S. Varadaraj – Chief Financial Officer
  • Mr. Burjis Godrej – Managing Director (Astec LifeSciences)
  • Mr. Arijit Mukherjee – Chief Operating Officer (Astec LifeSciences)

Call Access Information

The company has provided multiple dial-in options for participants across different regions. Domestic participants can use the primary number +91 22 6280 1224 or secondary number +91 22 7115 8125.

Region: Dial-in Number
India Primary: +91 22 6280 1224
India Secondary: +91 22 7115 8125
Hong Kong: 800 964 448
Singapore: 800 101 2045
UK: 0 808 101 1573
USA: 1 866 746 2133

Session Format

The conference call will commence with a brief management discussion on the Q3FY26 and 9MFY26 earnings performance. This will be followed by an interactive Question & Answer session where analysts and investors can engage directly with the management team.

Participants are encouraged to pre-register to avoid wait time. For additional information, participants can contact Siddharth Gadekar, Associate Director – Chemicals, Metals & Mining at Equirus Securities, or Shivansh Singh, Associate – Chemicals, Metals and Mining at the same firm.

The notification was signed by Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, and the information is also available on the company's website at www.godrejagrovet.com .

Historical Stock Returns for Godrej Agrovet

1 Day5 Days1 Month6 Months1 Year5 Years
-1.00%+0.02%+24.43%-14.44%-14.65%+32.07%

More News on Godrej Agrovet

1 Year Returns:-14.65%